Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
09/28/2005 | EP1578957A1 Formable and settable polymer bone composite and method of production thereof |
09/28/2005 | EP1578924A2 Genomic screen for epigenetically silenced tumor suppressor genes |
09/28/2005 | EP1578719A2 Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof |
09/28/2005 | EP1578536A2 Prefilming atomizer |
09/28/2005 | EP1578501A2 A system for administering a combination of therapies to a body lumen |
09/28/2005 | EP1578455A2 Radioisotope-associated polymeric hydrogel microspheres and methods for producing and using the same |
09/28/2005 | EP1578450A1 Amplification of biotin-mediated targeting |
09/28/2005 | EP1578449A2 Compositions of benzoquinolizine carboxylic acid antibiotic drugs |
09/28/2005 | EP1578448A1 Compositions of cholesteryl ester transfer protein inhibitors and hmg-coa reductase inhibitors |
09/28/2005 | EP1578443A2 Compositions comprising antigen-complexes, method for making same as well as methods of using the antigen-complexes for vaccination |
09/28/2005 | EP1578437A1 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
09/28/2005 | EP1578435A2 Treatment of ophthalmic conditions with kpv and kpv dimers |
09/28/2005 | EP1578422A2 A physically and chemically stable nicotine-containing particulate material |
09/28/2005 | EP1578421A2 Pharmaceutical preparations for treatments of diseases and disorders of the breast |
09/28/2005 | EP1578415A1 Dosage forms comprising a cetp inhibitor and an hmg-coa reductase inhibitor |
09/28/2005 | EP1578410A1 Method for preventing abuse of methylphenidate |
09/28/2005 | EP1578408A2 Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
09/28/2005 | EP1578407A2 Fast dissolving films for oral administration of drugs |
09/28/2005 | EP1578406A1 Modified release pharmaceutical composition |
09/28/2005 | EP1578405A1 Polymeric microparticulates for sustained release of drug and their preparation methods |
09/28/2005 | EP1578404A2 Method of encapsulating an active lipid-soluble substance by preparing a pit emulsion and emulsion obtained |
09/28/2005 | EP1578403A2 Modified release compositions of milnacipran |
09/28/2005 | EP1578400A1 Emulsions including surface-modified inorganic nanoparticles |
09/28/2005 | EP1578399A2 Methods for rapid identification of pathogens in humans and animals |
09/28/2005 | EP1578398A2 Stable, non-aqueous, single-phase gels and formulations thereof for delivery from an implantable device |
09/28/2005 | EP1578395A1 Nasal stick for the applocation of medicaments and skin care substances |
09/28/2005 | EP1578394A1 Antibody-containing particles and compositions |
09/28/2005 | EP1578393A2 Primary rat hepatocyte toxicity modeling |
09/28/2005 | EP1578355A2 Improved compositions of pegylated soluble tumor necrosis factor receptors and methods of preparing |
09/28/2005 | EP1578350A2 Sustained-release gel coated compositions |
09/28/2005 | EP1578348A2 Formulation comprising bioactive agents and method of using same |
09/28/2005 | EP1578342A2 Process for preparation of programmed liberation composition with venlafaxine and the resulting product |
09/28/2005 | EP1578325A2 Stable topical drug delivery compositions |
09/28/2005 | EP1578246A2 Device and method for examining a body lumen |
09/28/2005 | EP1578211A2 Kolla 2-desiccated avian sternal cartilage powder |
09/28/2005 | EP1578193A2 Method for freeze-drying nucleic acid/block copolymer/cationic surfactant complexes |
09/28/2005 | EP1523287A4 Materials with both bioadhesive and biodegradable components |
09/28/2005 | EP1450838A4 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
09/28/2005 | EP1439846A4 Storage-stable human fibrinogen solutions |
09/28/2005 | EP1427292B1 Chewing gum in powder form and a method of preparation |
09/28/2005 | EP1399032B1 Improved hard sugar coating method |
09/28/2005 | EP1320357A4 Topical polymeric antimicrobial emulsion |
09/28/2005 | EP1292598B1 Process for drying amoxicillin |
09/28/2005 | EP1178781B1 Multilayer pharmaceutical product for release in the colon |
09/28/2005 | EP1086141B1 Aloe pectins |
09/28/2005 | EP1052979B1 Device for releasing substances |
09/28/2005 | EP0646022B1 Prosthetic devices having enhanced osteogenic properties |
09/28/2005 | CN2728490Y Flexible medicinal plaster |
09/28/2005 | CN1675281A Biodegradable phase separated segmented multi block co-polymers |
09/28/2005 | CN1675229A Sulfur-containing phospholipid derivatives |
09/28/2005 | CN1675212A 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
09/28/2005 | CN1675003A Solid flowable powder with high liquid loading |
09/28/2005 | CN1674941A Solid nano-medicine and preparing method thereof |
09/28/2005 | CN1674940A Topical anhydrous and ethanol-free ascomycin compositions |
09/28/2005 | CN1674928A Method for treatment of indwelling catheter occlusion using fibrinolytic metalloproteinases |
09/28/2005 | CN1674923A Non-polymeric hematopoeitic cell clots for delivery of active agents |
09/28/2005 | CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis |
09/28/2005 | CN1674920A Process for preparing a sterile high molecular weight hyaluronic acid formulation |
09/28/2005 | CN1674916A The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
09/28/2005 | CN1674914A Female hormone-containing patch |
09/28/2005 | CN1674913A Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
09/28/2005 | CN1674910A Combination of azelastine and steroids |
09/28/2005 | CN1674903A Composition for transnasal absorption |
09/28/2005 | CN1674896A Pharmaceutical compositions comprising FK506 derivatives and the ir use for the treatment of allergic diseases |
09/28/2005 | CN1674891A Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
09/28/2005 | CN1674887A Aerosol formulation for inhalation comprising an anticholinergic |
09/28/2005 | CN1674886A 软胶囊制剂 Soft capsule preparation |
09/28/2005 | CN1674882A Aripiprazole complex formulation and method |
09/28/2005 | CN1674878A Immunomodulatory compositions, methods of making, and methods of use thereof |
09/28/2005 | CN1674877A Release controlled multiple unit drug delivery systems |
09/28/2005 | CN1674876A Film coating for tablets and caplets |
09/28/2005 | CN1674875A Anti-microbial compositions and methods of using same |
09/28/2005 | CN1674874A Process for coating a pharmaceutical particle |
09/28/2005 | CN1674873A Pharmaceutical compositions |
09/28/2005 | CN1674872A Crystalline drug particles prepared using a controlled precipitation (recrystallization) process |
09/28/2005 | CN1674871A Crystalline drug particles prepared using a controlled precipitation process |
09/28/2005 | CN1674870A Liposomes containing biologically active compounds |
09/28/2005 | CN1674869A Cochleates without metal cations as the bridging agents |
09/28/2005 | CN1674868A Ophtalmic ointment composition comprising a drug, an ointment base and a solubling/dispersing agent |
09/28/2005 | CN1674867A Antigenic compositions |
09/28/2005 | CN1674866A New sexual-dysfunction-compound-containing rapid-onset pharmaceutical formulations comprising cocoa powder and use thereof |
09/28/2005 | CN1674864A Topical formulation for prevention and treatment of acne |
09/28/2005 | CN1674863A Antiaging composition |
09/28/2005 | CN1674854A A capsule filling machine |
09/28/2005 | CN1674841A Ophthalmic drug delivery system |
09/28/2005 | CN1674786A Coated polyunsaturated fatty acid-containing particles and coated liquid pharmaceutical-containing particles |
09/28/2005 | CN1672745A Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
09/28/2005 | CN1672732A Stable recombinant solid alpha-interferon composition |
09/28/2005 | CN1672731A Interferon spray for lung administration and its prepn process |
09/28/2005 | CN1672728A Extract of star of bethlehem and its prepn process, medicinal composition and use |
09/28/2005 | CN1672726A Life-prolonging Chinese medicine prepn of haw |
09/28/2005 | CN1672725A Medicine for resisting inflammation, contracting uterus and eliminating tumor and its prepn process |
09/28/2005 | CN1672724A Diuretic and menstruation-regulating medicine and its prepn |
09/28/2005 | CN1672720A Prepn process of Chinese medicine nano prepn |
09/28/2005 | CN1672718A 橄榄钙片 Olive calcium |
09/28/2005 | CN1672716A Chinese medicine granule for preventing and treating respiratory tract infection |
09/28/2005 | CN1672712A New recipe and prepn process of blood fat reducing medicine |
09/28/2005 | CN1672711A Urotoxin eliminating capsule and its prepn |
09/28/2005 | CN1672710A Urotoxin eliminating effervescent tablet and its prepn |
09/28/2005 | CN1672709A Urotoxin eliminating tablet and its prepn |